AEON - AEON Biopharma, Inc.
1.06
0.030 2.830%
Share volume: 39,043
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$1.03
0.03
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-12-2024 | 11-13-2024 | 03-24-2025 | 05-14-2025 | 11-14-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | ||||
| Operating expenses | 10.381 M | 7.760 M | 4.016 M | 5.667 M | 3.950 M | 2.530 M | |
| Selling general and admin | 4.649 M | 3.321 M | 3.044 M | 2.629 M | 3.125 M | 1.933 M | |
| Research and development | 5.732 M | 4.439 M | 972.000 K | 3.038 M | 825.000 K | 597.000 K | |
| Total expenses | 74.150 M | -153.473 M | 4.016 M | 2.322 M | 462.000 K | 2.493 M | |
| -306.98% | 102.62% | -42.18% | -80.10% | 439.61% | |||
| Operating income | -74.150 M | 153.473 M | -4.016 M | -2.322 M | -462.000 K | -2.493 M | |
| Ebit | -118.018 M | 164.112 M | -6.171 M | 1.987 M | 0.000 | 0.000 | |
| Pretax income | -118.018 M | 164.112 M | -6.171 M | 2.082 M | 9.095 M | -4.538 M | |
| -239.06% | -103.76% | -133.74% | 336.84% | -149.90% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -118.018 M | 164.112 M | -6.171 M | 2.082 M | 9.095 M | -4.538 M | |
| 239.06% | -103.76% | 133.74% | 336.84% | -149.90% |